Analytical Services

Bruker In Vivo Xtreme Imaging System

Epistem’s facilities include the first Bruker In Vivo Xtreme Imaging System in the UK. The high resolution imaging system combines four modalities; luminescence, fluorescence, radioisotope imaging and X-ray. This sophisticated system enables high throughput, flexible imaging with rapid multimodal acquisition and is specifically designed for complex pre-clinical investigations. Combined with established expertise in imaging, this state-of-the-art system is a powerful addition to Epistem’s in vivo preclinical models. 

Capabilities of Epistem’s Imaging Service: 

  • Non-invasive longitudinal tumour xenograft imaging
  • Stem cell tracking
  • Imaging of inflammation
  • Optical imaging of clinical PET probes with Cherenkov radiation
  • Tracking and validating single or multimodal nanoparticles 
  • Imaging and validating new probes and biomarkers
  • Non-invasively image changes in signalling cascades
  • Discover how genetics, small molecules and therapeutics affect biochemical pathways
  • Quantify changes in bone and soft tissue phenotype
  • High throughput pharmacodynamic studies

Epistem's imaging service can be used to support in-house models including:

Oncology
Inflammation

 

The Bruker In Vivo Extreme Imaging System is a preclinical imaging solution by Bruker

The Bruker In Vivo Xtreme Imaging System

The Bruker In Vivo Xtreme Imaging System

© 2014-17 Epistem Ltd. : : last modified: 16 Jan 2017

Epistem Ltd is a division of genedrive plc